Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Increasing MAT Engagement With Financial Incentives [NA]
A Rowan University-sponsored clinical trial tested whether financial incentives increase engagement in medication-assisted treatment for opi…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT) [NA]
ClinicalTrials.gov study update for Project COMMIT reports completed status and posted results of a trial evaluating coordinating opioid use…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Physical Activity as Adjunct Treatment for Opioid Substitution Therapy [NA]
A clinical trial studying physical activity as an adjunct to opioid substitution therapy has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder [Phase 2]
A Phase 2 clinical trial sponsored by the University of Vermont evaluating low nicotine content cigarettes in individuals with tobacco use d…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal [Phase 2]
This document reports a Phase 2 clinical trial evaluating probenecid as a novel treatment to alleviate symptoms of opioid withdrawal, curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Observational Study on the Incorporation of Opioids and Their Metabolites Into Hair of Pediatric Patients
A completed observational study evaluating how opioids and their metabolites are incorporated into the hair of pediatric patients.
-
FDA approval · 2025-03-28FDA Approved: BRIXADI — Supplemental Application (Braeburn Inc.)
FDA approved a supplemental application for BRIXADI (buprenorphine) from Braeburn Inc., updating the labeling of this buprenorphine product.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP [Phase 4]
Phase 4 clinical trial from the University of Connecticut investigating optimized HIV prevention for people who inject drugs on PrEP; curren…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain [NA]
Clinical trial NCT03363243, STOP: Self-regulation Therapy for Opioid Addiction and Pain, conducted by the University of Colorado, Denver, ha…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: The Effect of Chronic Pain on Delay Discounting in Methadone Patients [Phase 1]
A Phase 1 study evaluated whether chronic pain influences delay discounting in patients on methadone for opioid use disorder; the trial was …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2). [Phase 1]
This Phase 1 trial update reports drug–drug interaction safety findings and the efficacy, safety, pharmacokinetics, and pharmacodynamics of …
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Improving Social Connectedness Through Digital Health to Enhance Recovery from OUD Among the Justice Involved Population [NA]
Clinical trial assessing whether digital health interventions aimed at improving social connectedness can enhance recovery from opioid use d…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study [Phase 1]
Phase 1 safety, tolerability and pharmacokinetics study evaluating NYX-783 with oxycodone in opioid use disorder has completed.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Opioid Misuse in Patients with Cancer
Rigshospitalet, Denmark is recruiting participants for a clinical study evaluating opioid use and misuse in patients with cancer, particular…
-
EMA approval · 2025-03-21EMA Authorised: Buvidal (buprenorphine) — Camurus AB
The EMA authorised Buvidal, a long-acting buprenorphine injection for opioid use disorder, with Camurus AB as the marketing authorization ho…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery [Phase 4]
A Phase 4 trial sponsored by Yale University evaluating liposomal bupivacaine (Exparel) for post-cesarean analgesia was terminated, with res…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Injectable Buprenorphine in Prison: a Preference Trial [Phase 4]
Phase 4 clinical trial update assessing injectable buprenorphine for opioid use disorder in incarcerated individuals. The trial status is no…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics) [NA]
The Project MIMIC trial evaluating motivational incentives in clinics for opioid use disorder has completed, with results posted on 2025-03-…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal [Phase 2]
Phase 2 trial evaluating inhaled cannabis (vaped marijuana) to attenuate naloxone-precipitated withdrawal in the context of opioid overdose;…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: FOREward Together: Training Peer Recovery Coaches to Promote Retention and Adherence to MOUD [NA]
A completed clinical trial evaluated a training program for peer recovery coaches to improve retention and adherence to medications for opio…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment [NA]
A completed clinical trial evaluating whether mindfulness training reduces opioid use and anxiety in people receiving buprenorphine for opio…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Buprenorphine-Fentanyl Interaction Study [Phase 1]
Phase 1 clinical trial update evaluating the interaction between buprenorphine and fentanyl in healthy volunteers and those with opioid use,…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Contingency Management to Enhance Office-Based Buprenorphine Treatment [NA]
This clinical trial update reports the completion and posted results of a study evaluating contingency management to improve office-based bu…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Brain Training for Substance Use Disorders [NA]
A brain-training study for opioid use disorder is currently recruiting, as part of Neurotype Inc.'s clinical trial.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse [NA]
A completed clinical trial evaluating Mindfulness Oriented Recovery Enhancement for chronic pain and opioid relapse has posted results (2025…